Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • The Astrology of Overnight Success: Acharya Lavbhushan Explains Raj Yogas Lifestyle
  • Vaseem Qureshi launches most ambitious venture ‘Vedat Marathe Veer Daudle Saat’ to be directed by Mahesh Manjrekar featuring Akshay Kumar Entertainment
  • Primex Media Services awarded as the Fastest Growing PR Agency Business
  • Filaantro: Crowdfunding for a Cause Press Release
  • Sabr Associates LLP, Gujarat goes global with Make in India exports Business
  • Garv Foundation celebrates the grand success of ‘Garv Awards’ Business
  • Eco Recycling updates on expanded capacity of E-waste & Li-ion Batteries recycling Business
  • Aman Singh Bisht: The perfect inspiration for upcoming entrepreneurs Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Doctors’ Day 2025: Top Cardiologists’ Insights on the Rise of Heart Issues in Young Adults Health
  • Gut Health’s Scarlet Secret: How Cranberries Shape Microbial Harmony Health
  • World Heart Day 2025: Rising Heart Disease in the Young – Why Waiting Is Dangerous Health
  • IPA MP State Branch, Indore Received Special Appreciation Award at Ipc-2023 Held in Nagpur: Dr. Anil Kharia, Honorary President, IPA MP STATE BRANCH Received the National Award during IPC 2023 Health
  • The Healing Center Homeopathy: Leading the Way in Evidence-Based Homeopathy Across India Health
  • From death to life, the miracle of heart transplantation – Dr. Dhiren Shah, Director, Heart & Lung Transplant Program Marengo CIMS hospital Health

Recent Posts

  • Supreme Power Equipment Limited Secures Rs 128 Cr Orders; Order Book Strengthens to Rs 577.72 Cr
  • Meet 10 Companies Driving Innovation and Growth in 2026
  • “Line of Control”, a powerful cinematic adaptation of internationally acclaimed novel The Collaborator
  • The Sovereign Traveler: Why India’s Gen Z is Redefining the Solo Trip
  • Subh Housing Announces Rs 200 Cr Investment in Gurugram with Spanish- Inspired ‘Seggovias’ on SPR Road

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Parul Institute of Performing Arts creates a space for artistic expressions through Rang initiative with Dr. Sonal Mansingh Press Release
  • Meet MBA Turned Astrologer, Dr. Virat Kanadia Lifestyle
  • Dr Mohammed Khan Received the 14th Bharat Ratna Dr A P J Abdul Kalam Award 2022 Lifestyle
  • LTC Original Prevents Diabetic And Health Conscious Customers From Compromising On Taste With Its Dia Rice Business
  • ACME Solar Holdings IPO Opens at Rs 2900 Crore Highlighting Strong Renewable Energy Market Business
  • Globe Civil Bags New INR 2.37 Crore Institutional Infra Order in New Delhi Business
  • Eurosport India Announces Shikhar Dhawan as MotoGP™ Brand Ambassador Business
  • Sayantani Putatunda: Bengal’s Untamed Storyteller the Film World Forgot to Discover Entertainment

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme